Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
about
Targeting the tumor vasculature to enhance T cell activityT cell exclusion, immune privilege, and the tumor microenvironmentCloning and characterization of porcine 4Ig-B7-H3: a potent inhibitor of porcine T-cell activationUltrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model.B7-H3 and B7-H1 expression in cerebral spinal fluid and tumor tissue correlates with the malignancy grade of glioma patients.Prognostic biomarkers in ovarian cancer.B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcomeB7-h3 and its role in antitumor immunityB7-H3 expression in breast cancer and upregulation of VEGF through gene silenceExpression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patientsT cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.Structure and cancer immunotherapy of the B7 family member B7xIdentification and characterization of angiogenesis targets through proteomic profiling of endothelial cells in human cancer tissues.Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular ImagingExpression levels of B7-H3 and TLT-2 in human oral squamous cell carcinoma.B7-H6 expression correlates with cancer progression and patient's survival in human ovarian cancer.Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response.Endothelial cells in the eyes of an immunologistB7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells.B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma.Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3.B7-H3 expression associates with tumor invasion and patient's poor survival in human esophageal cancerPotentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer.Host b7x promotes pulmonary metastasis of breast cancerSoluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway.Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicineClinical significance of the induction of macrophage differentiation by the costimulatory molecule B7-H3 in human non-small cell lung cancer.Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responsesThe Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection.Control of the adaptive immune response by tumor vasculature.Structure and T cell inhibition properties of B7 family member, B7-H3.Peritoneal immune system in patients with advance epithelial ovarian cancer.MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY.Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer.Deciphering and reversing tumor immune suppression.B7-H3-mediated tumor immunology: Friend or foe?The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1.
P2860
Q27026329-4564CB4E-32B6-4F71-A98E-D1084C7A7A8FQ28259872-36C2613E-F0AC-476A-84E4-0AA82877AA6FQ28743206-11BC653C-D7BC-4DDF-9C69-F0609ACF36E8Q30417587-373FBF94-FA95-42E9-83FB-03C01C19F0C8Q33967711-DC592396-CB90-4DE9-9F3B-C9606606D576Q34086636-2FAA34E9-0754-4E94-A204-3D6873BEA7CCQ34105913-AF100E71-FDAF-4886-9DB7-B113356F8BD2Q34356712-56139106-860D-4D5C-8471-F1FB6B1AB898Q34446315-50CAF844-73BA-4F52-9487-125E82AB5E98Q34538321-C26F9771-190B-4D55-A79D-2ADF1347E4A3Q34577158-B74A44F5-CBD8-4604-9EEF-359142293A3BQ34605921-75EFBBFF-DF75-4F89-93E4-9D87A26ED89EQ35043619-151289F9-8AD5-44D8-A7C2-04E7DD6823FEQ35104159-8ADE0EEF-900C-4BC1-AD2B-9E522CC5747EQ35751840-83A3DE7A-257A-4E89-8A1C-B3BC911FED07Q35871253-FF9D6EC3-57DA-49BE-BC90-B597F97F1961Q36095328-498B2273-F07F-4C8B-ABD3-01D29E2F23C9Q36207260-47F1DC99-EA3C-4765-9F2D-7EC9DDC1EA44Q36252688-2BB2A571-ED86-4A4F-91AB-E0F974D47F78Q36303510-B47AD8AE-3EEA-4C35-ADC2-22F12A1379AAQ36429035-9D0775E4-A250-4DF3-9DEC-15041E524F9DQ36444198-C13F1BCB-65A5-4523-B6F0-1E92EC011608Q36516689-76CD5D2E-9F43-4081-9174-E323B8392923Q36664213-B837BAA1-BE38-436B-A0BB-4425022E3B92Q36718223-CE99F09E-7FB0-4E65-AC37-B7CD23B02DD4Q36980286-B17A0F07-56E0-44FF-9345-D44B08FCE235Q37158481-6AD9EB9D-83EC-4F07-84FB-88D502FA9520Q37224420-6C1D0819-4BE8-4F57-9752-3771C4007772Q37269305-AD4AF9F1-CD0F-4011-9961-E5D47695B21FQ37292542-5205CE9A-C830-430F-BF9A-73436421D02EQ37516448-CA124812-FB6E-4906-B7D7-7C0A236B8DBBQ37656365-44C1292D-538E-44AF-9CF9-FDC9A6334C01Q37683575-ABC31A8D-1536-4909-BA49-79320F9B04B4Q37721055-33ADE6FB-C92C-45B5-A695-89AF68711AEDQ37873925-E14D5EFA-8F0C-47F7-8CEE-CB4D293F6CCCQ38040302-1F1D5224-E3D4-4322-B23C-350B0C51B231Q38091267-22CCD4AF-D1FA-499F-A1B0-2115F972A742Q38124437-5041D759-764A-4E8C-A467-890BFB848612Q38135281-142D7790-0ADE-4CA8-B221-C80E25336713Q38684886-28FC19BB-93B1-4CCE-98CD-A7E035561412
P2860
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
@ast
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
@en
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
@nl
type
label
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
@ast
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
@en
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
@nl
prefLabel
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
@ast
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
@en
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
@nl
P2093
P2860
P1433
P1476
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
@en
P2093
Andrew Wilton
David R Spriggs
Howard T Thaler
Jakob Dupont
Manonmani Arul
Peggy S Sullivan
Rebecca Waitz
Susan F Slovin
Victor E Reuter
P2860
P2888
P304
P356
10.1038/MODPATHOL.2010.95
P577
2010-05-21T00:00:00Z
P5875
P6179
1035683243